We prefer to focus our analysis on disruptive new applied sciences or “angles” on established industries—new alternatives which can be all about turning one thing on its head in a approach that gives up the potential to drive critical progress for buyers.
In the present day’s focus inventory is Mangoceuticals Inc (NASDAQ:MGRX), makers of the Mango therapy for erectile disfunction. Created utilizing a particular formulation that includes the identical lively ingredient as in Cialis (Tadalafil), every a part of the Mango formulation performs a vital position in serving to males obtain optimum efficiency.
The corporate has famous that it believes the important thing to Mango’s success lies in its distinctive mix of elements. They’ve all been historically used to deal with ED of 1 sort or one other. Mango incorporates all of them for max efficacy.
Mango is a prescription remedy that have to be accredited by a doctor. Nevertheless, the corporate has apparently labored to streamline that aspect of issues by its on-line telehealth system that connects sufferers to Mango’s community of medical suppliers, who’re standing by to evaluate and approve a prescription if medically applicable.
Mango additionally seems to have one other benefit over the competitors: it’s a quickly dissolved pill (RDT). It will get absorbed orally, so it takes impact sooner—like 10-Quarter-hour. And it lasts as much as 36 hours.
About the one factor going in opposition to MGRX proper now’s simply that it has been flying below the radar.
Into the Highlight
Whereas MGRX has been flying below the radar till now, which may be set to vary. The corporate lately introduced the launch of a brand new viral video advert marketing campaign: “Some Issues Are Higher Laborious”.
The marketing campaign facilities round a single full-length video product of a number of brief movies, all designed to go viral. It’s definitely worth a watch.
Based on the corporate, the entire package deal will probably be broadly distributed, collectively as an entire and individually, throughout a number of social media platforms, together with, however not restricted to, Fb, Instagram, Snapchat, TikTok, YouTube, Google, and Twitter.
The actual kicker is the ‘angle’ MGRX is taking in its advertising and marketing technique: The composition is designed to bolster the central theme that “Some Issues Are Higher Laborious”, leveraging humor and an open and assured framing of the pursuit of male well being and private enchancment to defuse social taboos and normalize ED as a generally shared purposeful impediment to wholesome male experiences.
In different phrases, the entire stigma round ED is the most important hurdle ED manufacturers face in advertising and marketing and promoting product. MGRX might be the one participant on the sector instantly confronting that reality and navigating round it to the endzone.
“This marketing campaign is anticipated to assist to additional place Mango within the ED market as a uniquely accessible useful resource which has the objective of serving to regular males obtain better success and self-confidence whereas avoiding model affiliation with social discomfort,” acknowledged MangoRx Co-Founder and CEO, Jacob Cohen. “We consider we now have opened up a disruptive new lane on this quickly rising $3.5 billion market. Peak efficiency is an efficient factor. Making your life higher is an efficient factor. Cultural limitations to speaking frankly about that pursuit are a nasty factor. But, till Mango got here alongside, that’s usually how this market tacitly operated. We consider that was a blind spot and the Mango model is making an attempt to carve out a brand new mannequin. We consider that the ‘Some Issues Are Higher Laborious’ viral digital marketing campaign is an ideal automobile to press our incipient branding benefit.”
Based on the corporate’s launch, the “Some Issues Are Higher Laborious” digital advert marketing campaign represents the Firm’s second try to make use of artistic advertising and marketing to widen the branding hole with its rivals and to be the primary ED answer to efficiently broaden to incorporate a youthful demographic. The Firm’s first industrial, which initially debuted on YouTube in November 2022, has already been seen almost 6 million instances.
The viral advert is prone to be nice for gross sales of Mango. However will it spotlight the inventory?
Definitely. At the very least to some extent. Nevertheless, there’s additionally proof that MGRX is getting its recreation on with investor relations.
The truth is, simply final week, the Firm’s Co-Founder and CEO, Jacob Cohen, together with the MangoRx household, together with Firm officers and members of the manager administration workforce, had been on the Nasdaq MarketSite Tower in Instances Sq. to ring the Nasdaq closing bell stay on nationwide tv.
“It is a very thrilling time for MangoRx as we scale up our model presence and sit up for many great alternatives for achievement that lie forward of us in 2023,” acknowledged Cohen. “To assist seize this second, we’re honored to go to the Nasdaq MarketSite in Instances Sq. to ring the Nasdaq Closing Bell and to forged a highlight on our distinctive method to males’s well being and self-confidence.”
We are able to possible count on different strikes that seize extra highlight for MGRX, which ought to be all to the nice for its shareholders given what seems to be a really well-positioned disruption technique in a multi-billion-dollar market.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com